The present disclosure relates to a medical device for using in accessing the cardiovascular system. More particularly the present disclosure relates to a hybrid transseptal dilator for facilitating a transseptal procedure for providing left heart access
In order that the invention may be readily understood, embodiments of the invention are illustrated by way of examples in the accompanying drawings, in which:
When performing a transseptal procedure to gain access to the left atrium of a heart, a physician typically uses a sheath and dilator to support a crossing or puncturing device. In some cases, a physician may not be able to cross through to the left atrium sheath as the transition between sheath and dilator may get stuck or snag at the tissue boundary, and as a result the sheath may not be able to cross through the perforation (or it crosses with difficulty). In other words, the tissue may get hung up at the sheath/dilator interface. Thus, the use of multiple device in a transseptal procedure may make it difficult for the operator to complete the procedure due to the material transitions between various devices which may get caught at the septal tissue interface. The problem of a transseptal puncture being performed using a crossing device which is supported by a sheath and dilator set having a transition which may snag on tissue when crossing the septum, can be addressed by using a hybrid dilator (described herein) instead of the sheath and dilator set to thereby eliminate the transition, wherein the hybrid dilator has the appropriate functionality (flexibility, pushability, torqueability, distal taper, etc.) to facilitate a smooth crossing.
In one broad aspect, embodiments of the present invention include a hybrid dilator for use with a crossing device in tissue puncturing procedures, the hybrid dilator comprising: a dilator shaft defining a lumen for receiving a crossing device therethrough, the dilator shaft being structured to provide support for the crossing device when the crossing device is used to create a puncture in a tissue; and a distal tip having an outer diameter which tapers down to an outer diameter of the crossing device for providing a smooth transition between the crossing device and the distal tip when the crossing device is inserted through the lumen and protrudes beyond the distal tip. In some such embodiments, the dilator shaft comprises an inner layer, an outer layer, and a torque layer therebetween.
In another broad aspect, embodiments of the present invention include a kit for puncturing a tissue, the kit comprising: a crossing device having a puncturing feature; and a hybrid dilator, wherein the dilator has a dilator shaft defining a lumen for receiving the crossing device therethrough, the dilator shaft being structured to provide support for the crossing device when the crossing device is used to create a puncture in a tissue. The hybrid dilator also includes a distal tip which has an outer diameter which substantially tapers down to an outer diameter of the crossing device for cooperatively providing a smooth profile when the hybrid dilator is advanced through a tissue over the crossing device. In some embodiments of the kit, the crossing device is a mechanical needle with a sharp tip, while in some other embodiments, the crossing device is configured for delivering energy to a tissue.
In another broad aspect, embodiments of the present invention include a system for puncturing a tissue, the system comprising: a crossing device having a puncturing feature which is operable to deliver energy to a tissue; an electrosurgical generator which is operable to provide energy to the puncturing feature; and a hybrid dilator, wherein the hybrid dilator has a dilator shaft defining a lumen for receiving the crossing device therethrough, the dilator shaft being structured to provide support for the crossing device when the crossing device is used to create a puncture in a tissue. The hybrid dilator also includes a distal tip having an outer diameter which substantially tapers down to an outer diameter of the crossing device for cooperatively providing a smooth profile when the hybrid dilator is advanced through a tissue over the crossing device.
In yet another broad aspect, embodiments of the present invention comprise a method of using a hybrid dilator and a crossing device for puncturing a septum of a heart, the method comprising the steps of: (a) positioning a distal tip of the hybrid dilator at a desired site of the septum; (b) using the hybrid dilator for supporting a crossing device, located within a lumen of the hybrid dilator, as the crossing device is advanced beyond the distal tip of the hybrid dilator to puncture the septum; and (c) advancing the hybrid dilator over the crossing device thereby dilating the desired site.
In one broad aspect, a hybrid dilator is provided as a composite device that comprises one or more requisite features of a transseptal dilator or sheath or a combination thereof in a single device, in order to provide the combined functionality of a transseptal sheath and dilator assembly in an optimized manner. Some of these features that provide the combined functionality of a sheath and dilator assembly may include shaft rigidity, curvature and internal and exterior tapers that may be incorporated along a distal portion of the hybrid dilator including along a distal tip to facilitate crossing of the hybrid dilator. Additionally, in some case the hybrid dilator may include features that facilitate handling of the hybrid dilator and/or provide directionality information such as tactile cues or indications to convey the direction of the distal tip curvature for facilitating the transseptal procedure. In some instances these features may be incorporated into a proximal portion of the hybrid dilator such as within a combined proximal hub.
In another broad aspect, an optimized method is provided to perform a transseptal medical procedure. The method provides for streamlining the procedural workflow by providing a hybrid dilator that includes enhanced functionalities of a conventional transseptal sheath and dilator assembly. With the hybrid dilator of the present invention, a reduced number of devices may be required in order to complete the transseptal procedure, which enhances procedural efficiency while reducing procedural time and complexity.
In some situations, where a standard sheath and dilator assembly are successful in completing an initial transseptal access procedure, the sheath may not be large enough to support subsequent advancement of a relatively larger outer diameter (OD) catheter for treatment to the left side of the heart. As a result, the sheath and dilator assembly may have to be removed and the catheter may then be advanced over a guidewire that is in place across
the septum to thereby be advanced into the left side of the heart. In other instances, the physician may want to use a large delivery sheath for complex procedures (such as \left atrial appendage closure/occlusion procedures) and knows that it may not be possible to cross with that product, so they may introduce a standard transseptal kit (that includes a sheath, dilator and guidewire) in order to cross and pre-dilate the septum. The three piece kit may then be removed for exchange, and then discarded, which results in the three products (sheath, dilator, guidewire) only being used for a short procedural time period. Thus, in some cases, the sheath and dilator assembly may only be useful to perform an initial transseptal puncture, leading to waste due to multiple devices being used. Furthermore, performing a transseptal procedure using multiple devices contributes to an increase in procedural time and complexity, and additional cost. Furthermore, with the emergence of more left atrial clinical interventions, there is a growing need for safe and reliable transseptal solutions.
In some embodiments, an oversized hybrid dilator is provided that reduces the number of physical/geometric transitions as well as the number of material transitions which can both cause difficulties or tactile obstructions for physicians when completing transseptal or other tissue crossings. Some examples include smooth lines and tapers to facilitate a seamless transition across tissue.
Additionally, the present inventors have discovered a method to perform a transseptal medical procedure that streamlines the procedural workflow by providing a hybrid dilator that replaces a conventional transseptal sheath and dilator assembly. With the hybrid dilator of the present invention a reduced number of devices may be required in order to complete a transseptal procedure. This reduces the number of parts that a physician is required to prepare and assemble for the transseptal procedure and introduce into the patient. The present method provides a dilator that is usable with a guidewire for access that replaces a sheath, dilator, and guidewire assembly.
With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of certain embodiments of the present invention only. Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
In some embodiments, a single piece/unitary device in the form of a hybrid dilator is provided that provides smooth tapers functions to facilitate both the crossing and the exchange of devices in a trans-septal procedure while still providing the physician with tactile feedback and distal curve indication that are substantially equivalent to those provided by a sheath/dilator assembly.
In accordance with an embodiment of the present invention, a hybrid dilator 100 is provided, as shown in
Dilator Shaft/Support and Columnar Strength/Positioning
The dilator shaft is formed from a smooth distal tubing 121 that is coupled to the molded proximal hub 112. The distal tubing 121 defines a lumen 122 there-through that narrows at the distal tip 140 and which may be used to flush the device prior to use. In some embodiments, since the hybrid dilator 100 is provided a single unitary device, this means that one product is to be flushed unlike the prior art sheath/dilator assembly where each product requires flushing. The dilator shaft provides mechanical properties to best facilitate procedural activities. At the distal tip 140, as illustrated further in
Distal End Curvature
In some embodiments of the present invention, the distal end 130 of the hybrid dilator 100 may be curved as shown in
In some such embodiments, the hybrid dilator 100 comprises a shaft formed from distal tubing 121 that is sufficiently rigid to enable positioning of a crossing device such as a puncturing needle or a guidewire to be advanced through it while maintaining the position of the assembly at a desired site, such as a fossa of a septum. As such, the hybrid dilator 100 functions to provide support and columnar strength to facilitate placement of the crossing device at the desired location. As disclosed above and as shown in
Distal Tip
More specifically, as shown in
In typical examples, as shown in
Some embodiments of the dilator shaft comprised of a relatively harder material (e.g. HDPE) have an inner diameter ID1 of about 0.072 inches (0.18 cm) to about 0.11 inches (0.28 cm). Other embodiments of the dilator shaft comprised of a relatively softer material (e.g. polyurethanes, polyether block amide) have an inner diameter ID1 of about 0.050 inches (0.13 cm) to about 0.11 inches (0.28 cm). Polyether block amide (PEBA) is a thermoplastic elastomer (TPE) and is known under the tradenames of VESTAMID® E (Evonik Industries) and Pebax (Arkema).
In the example shown in
In some embodiments, the taper angle TA may range from about 5° to about 15°. In some examples, the taper length of external taper T3 may range from about 1.0 cm to about 1.6 cm. In some embodiments, length of the external taper T3 ranges from about 0.4 inches (1 cm) to about 1 inch (2.5 cm). In one example, the taper length of external taper T3 may be about 1.0 cm with a taper angle TA of about 15°. In some embodiments, the wall thickness WTip at the distal edge 148 of the distal tip 140 is between about 4 thousandths of an inch (0.010 cm) to about 5 thousandths of an inch (0.013 cm). The wall thickness WTip is sufficient for maintaining mechanical integrity of the distal tip 140 while ensuring that it is not too thick to make it difficult for the distal tip 140 to cross a puncture site within the tissue.
In an alternative embodiment of the present invention, as shown in
Wall Thickness, Bending Stiffness and Torque
As discussed earlier with respect to
In an alternative embodiment the hybrid dilator is a 12.5 French OD dilator with an 8.5 French ID. The wall thickness Wp along the proximal length 123 of the distal tubing 121 is about 32 thousandths of an inch (0.081 cm). Bending stiffness for the particular example is about 4 N/mm and the torque is about 5 N cm.
In still a further alternative, the hybrid dilator 100 is a 12.5 French OD dilator with a 4.5 French ID. The wall thickness Wp along the proximal length 123 of the distal tubing 121 is about 55 thousandths of an inch (0.140 cm). Bending stiffness for the particular example is about 5.5 N/mm and the torque is about 7 N cm. In another example, the hybrid dilator is a 15 French dilator where the wall thickness is less than about 26.5 thousandths of an inch (0.067 cm) to provide adequate stiffness.
In some embodiments, a HDPE hybrid dilator 100 has: a 12.5F OD which is about 0.162-0.166″ (0.411-0.422 cm); a 4.5-8.5F ID (about 0.056-0.115 inches or about 0.142-0.292 cm); a wall thickness from about 0.025″ to about 0.055″ (about 0.064-0.140 cm), a stiffness of about 3.5 to 5.5 N/mm, and a torque transmission from about 4 to about 7 N cm.
In an alternative embodiment, the dilator shaft is comprised substantially of HDPE and includes: a 12.5 French OD (about 0.162″-0.166″ or about 0.411-0.422 cm); an 8.5 French ID (about 0.108″-0.115″ or about 0.274-0.2921 cm); a wall thickness from about 23.5 thousandths of an inch (0.06 cm) to about 29 thousandths of an inch (0.074 cm). Such embodiments may have a bending stiffness from about 2.5 to 3.5 N/mm and a torque transmission from about 4 to 4.5 N cm.
In another alternative embodiment, the dilator shaft is HDPE and has: a 12.5 French OD (about 0.162″-0.166″ or about 0.411-0.422 cm); a 7.5 French ID (about 0.095″-0.102″ or about 0.241-0.259 cm); and a wall thickness which is about 0.03-0.036″ (about 0.076-0.091 cm). Bending stiffness for such examples is about 3.5 to 4.5 N/mm and the torque transmission is about 4.5 to 5.5 N cm. In some specific embodiments, the wall thickness is about 32 thousandths of an inch (0.081 cm).
Another alternative embodiment includes the dilator shaft being comprised of HDPE and the shaft having: a 12.5 French OD (about 0.162″-0.166″ or about 0.411-0.422 cm); a 4.5 French ID (about 0.056″-0.063″ or about 0.142-0.160 cm); and a wall thickness of about 0.05-0.055″ (0.127-0.140 cm). Typically, bending stiffness for such embodiments is from about 5 to 6 N/mm and the torque is about 6 N cm to 7 N cm. In some specific embodiments, the wall thickness is about 55 thousandths of an inch (0.140 cm).
In some embodiments of the present invention Torque may range from about 1.0 N cm to about 7 N cm over a length of about 50 cm. In some examples the bending stiffness ranges from about 1.0 N/mm. to about 5.5 N/mm over a span of 50 mm.
Surface Finish
In some embodiments of the present invention, the distal tubing 121 may comprise different surface finishes to provide various amounts of friction along the exterior surface. In some embodiments, as above the distal tubing 121 may be formed substantially of HDPE. Alternatively, the dilator may be formed from multiple material layers or a composite material. In some such examples, the multiple layers may extend concentrically and longitudinally along the length of the distal tubing 121 in the form of multiple tubular layers. In one such example the inner layer or tubing comprises an HDPE or a low density polyethylene (LDPE) core with an outer layer of PEBAX (polyether block amide) extrusion. This may provide a relatively smoother exterior finish compared to HDPE. Furthermore, the PEBAX tubing allows for silicone coating to be disposed thereon to additionally provide a smooth coating on the exterior.
In an alternate embodiment of the present invention, as shown in
Alternatively, as shown in
Alternatives
In alternative embodiments of the present invention, the distal tip 140 may have a modified external taper T3. In some such examples, the geometry of the external taper T3 may be varied. As outlined previously, the distal tip 140 may have surface modifications along the external taper T3. The external taper T3 may be provided with a secondary bump 147a, the external taper T3 may be provided with divot 147b. Alternatively, the external taper T3 may be provided with a modified roughness.
In alternative embodiments, the ID of the distal tip 140, including internal taper(s), is modified in order to accommodate a crossing/puncturing device such as a needle (for example an RF needle). Alternatively, internal geometry may be modified in order to accommodate a crossing/puncturing device such as a guide wire (for example an RF guidewire). In some embodiments, the shaft distal tubing 121 comprises a single material. Alternatively, the shaft distal tubing 121 may comprise a composite material via co-extrusion or post extrusion processing/layering. In some examples, the shaft distal tubing 121 comprises a lubricious coating material along the exterior. In some such examples, the chemistry and/or processing of the lubricious coating material is varied to provide a suitable coating. In some embodiments, material may be used within the distal tubing 121, and for coating, in accordance with what is known in the art. In a further alternative of the present invention, the hybrid dilator 100 may be provided with forward facing ports along, the distal tip 140, to allow for fluid injection when a needle or a guidewire is positioned inside the hybrid dilator 100.
In some embodiments of the present invention the hybrid dilator 100 has been created to optimize the tubing stiffness/torque response. Also, the handle/hub 112 provides enhanced handing features (discussed further herein below). In some embodiments, as shown previously, the distal tip 140 is provided with two external distal tapers. In some embodiments, the internal controlled geometry may be provided in varying configurations.
Hybrid dilator 700 of
In embodiments which include a torque layer 704 between the inner and outer materials (HDPE and Pebax), the braid normally functions as an anchor between the inner and outer layers. Such embodiments may be manufactured using a reflow process which melts both the inner and outer layers into the braided layer whereby the braided layer mechanically joins the two materials together. Some such embodiments have a stainless steel braid and provide 8 N cm of torque transmission.
Making further reference to
In a specific embodiment of the hybrid dilator 700 shown in
Further alternative embodiments of hybrid dilator 700 include outer layer 708 of shaft 702 being made of thermoplastic to facilitate manufacturing. Some examples have only one internal lumen taper or more than two. Some further embodiments include an electrode configured for puncturing at the tip so that the one device can puncture, cross, and dilate.
Some embodiments include the shaft having an inner layer 706 made of HDPE and an outer layer 708 made of Pebax, wherein, during manufacture of the device, tip 720 and inner layer 706 are formed in the same extrusion of HDPE whereby tip 720 and inner layer 706 are continuous without any internal joint, which eliminates the risk of a sharp needle being advanced through the dilator catching at a joint between the dilator shaft 702 and tip 720.
Proximal Hub
The hybrid dilator 100 comprises a handle defined by a hybrid or combination proximal hub 112 at a proximal end thereof, as additionally shown in
comprises a custom insert molded HDPE Hub at the proximal end with a luer connector 115 and tactile features (defined by a side-port arm 117) to indicate the plane of distal curvature and provide similar handling characteristics. In some such examples, the proximal end 110 has a luer taper to allow for connection of medical syringes or fluid drips.
Proximal hub 112, as illustrated in
In some embodiments as shown in
In accordance with another embodiment of the present invention, a feature is provided within the valved proximal hub 212 to funnel device into the shaft tubing. In a particular case, a funnel guide 222 is provided to direct and align product inserted into valve 213 into the shaft tubing. The funnel guide is positioned distal of the valve 213. In some such examples, the funnel guide 222 is provided as a molded feature. In some embodiments, funnel guide 222 is configured such that it also centers the proximal end of the guidewire with respect to the valve. This centering directs the proximal end of the guidewire when it is inserted through the device's distal tip for the purpose of device exchange.
In a further alternative, as shown in
In alternate embodiments of the present invention, the proximal hub 212 may comprise material that is taken from the group consisting of pebax, HDPE, LDPE, and Nylon or a combination thereof to achieve desired lubricity and handling characteristics.
In still a further alternative, a proximal hub 112 is shown in
Alternatives
In some embodiments of the present invention, the proximal hub 112 or valved proximal hub 212 may comprise a molded hub. In some embodiments, the proximal hub 112 or valved proximal hub 212 may comprise HDPE. Alternatively, other materials may be used. In some embodiments, the geometry of the hub may be varied as may be suitable. In alternative embodiments of the valved proximal hub 212, the valve material and/or geometry may be varied as may be known in the art. In some such examples, the slit configuration and/or size may be varied to provide a suitable valve to meet the requirements of the procedure, such as a transseptal procedure. In still further alternatives, the material of the side-port tubing, and the ID and OD of side-port tubing may be selected and/or varied as may be known to a person skilled in the art. Similarly, in some examples, as shown in
In still a further alternative of the present invention, some embodiments of a hybrid dilator of the present invention may provide the simplicity of transseptal crossing, and yet may still allow an ablation catheter to be used with it in case the need arises.
Another aspect of the invention is a kit for puncturing a tissue comprising: a crossing device having a puncturing feature; and a hybrid dilator 100, wherein the dilator has a dilator shaft defining a lumen 122 for receiving the crossing device therethrough, the dilator shaft being structured to provide support for the crossing device when the crossing device is used to create a puncture in a tissue. The hybrid dilator also includes a distal tip 140 having an outer diameter which substantially tapers down to an outer diameter of the crossing device for cooperatively providing a smooth profile when the hybrid dilator 100 is advanced through a tissue over the crossing device. In some embodiments of the kit, the crossing device is a mechanical needle with a sharp tip, while in some other embodiments, the crossing device is configured for delivering energy to a tissue.
Another aspect of the invention is a system for puncturing a tissue comprising: a crossing device having a puncturing feature which is operable to deliver energy to a tissue; an electrosurgical generator which is operable to provide energy to the puncturing feature; and a hybrid dilator 100, wherein the hybrid dilator has a dilator shaft defining a lumen 122 for receiving the crossing device therethrough, the dilator shaft being structured to provide support for the crossing device when the crossing device is used to create a puncture in a tissue. The hybrid dilator also includes a distal tip 140 having an outer diameter which substantially tapers down to an outer diameter of the crossing device for cooperatively providing a smooth profile when the hybrid dilator is advanced through a tissue over the crossing device.
Methods of Performing a Transseptal Procedure Using a Hybrid Dilator of the Present Invention
In accordance with the present invention, a method of the present invention provides for streamlining the procedural workflow by providing a hybrid dilator that combines the functionalities of a conventional transseptal sheath and dilator assembly. With the hybrid dilator of the present invention a reduced number of devices may be required in order to complete the transseptal procedure, which enhances procedural efficiency while reducing procedural time and complexity.
In such example, a method of the present invention avoids the disadvantages associated with a conventional transseptal procedure.
As outlined herein above, embodiments of the present invention provide an optimized transseptal procedure In accordance with a method of the present invention, as shown in
Instead of a sheath, dilator and guidewire, a hybrid dilator 100 and guidewire may be used. The method additionally provides: at step 430, exchanging the guidewire for a crossing device 60 which comprises a puncturing device 62 [In some embodiments of the present invention, the puncturing device 62 may comprise a needle. In some such examples, the needle is a radiofrequency (RF) needle. Alternatively, the needle may comprise a mechanical needle. In other embodiments of the present invention, the puncturing device 62 may comprise a radiofrequency (RF) guidewire]; and at step 440 advancing the crossing device and the hybrid dilator across the septum 505 to create a trans septal puncture site 510 and dilate the puncture site 510 to facilitate advancement of one or more secondary devices 70 through the transseptal puncture site. The hybrid dilator 100, which may also be referred to as the step-up dilator, is provided as a simplified tool. It simplifies the procedural workflow by providing a one piece transseptal tool compared to a sheath and dilator (it is additionally usable with a guidewire and needle as shown). The hybrid dilator 100 is provided as a one/single oversized dilator and in use it reduces the number of physical/geometric transitions as well as the number of material transitions or tactile obstructions which may allow the physicians to complete a transseptal or other tissue crossings with greater ease. The hybrid dilator 100 reduces the changes of the hybrid dilator 100 from getting caught at the transseptal puncture site, by provided smooth lines and tapers to facilitate a seamless transition across tissue. This allows the hybrid dilator 100 to be advanced across the septum with greater ease. The method additionally provides for; at step 450, exchanging the crossing device 60 with a guidewire 80 and advancing the guidewire 80 into the left atrium; at step 360, removing the hybrid dilator 100; and at step 470, advancing the one or more secondary devices over the guidewire 80 into the left atrium 502 to complete the desired procedure.
In procedures where the physician wishes to use a relatively large delivery sheath for complex procedures (for example for cryoablation or LAA occlusion) and knows they cannot cross with that product, the physician can now introduce just the hybrid dilator 100 over a guidewire as discussed in step 420 using a single device to cross and pre-dilate the septum. The hybrid dilator 100 and the initial guidewire may then be removed for exchange, thus using only two products (hybrid dilator 100 and guidewire, instead of a standard sheath, dilator and guidewire kit). As such the improved method additionally provides at steps 460 and 470 removing just the hybrid dilator 100 to allow exchange with the secondary device such as a relatively large delivery sheath for complex procedures, wasting fewer products in the process.
Another embodiment of the method of uses a hybrid dilator 100 and a crossing device for puncturing a septum 505 of a heart. This embodiment of the method comprises the steps of: a) positioning a distal tip 140 of the hybrid dilator at a desired site of the septum; b) using the hybrid dilator 100 for supporting a crossing device, located within a lumen of the hybrid dilator, as the crossing device is advanced beyond the distal tip of the hybrid dilator to puncture the septum; and c) advancing the hybrid dilator over the crossing device thereby dilating the desired site. In some such embodiments, the crossing device is a mechanical needle and step (b) further includes applying force with the mechanical needle to the septum to thereby puncture the septum. In other embodiments, the crossing device is configured for delivering energy, and step (b) further includes supplying electrical energy to the crossing device to thereby puncture the septum. Some embodiments further comprise a step (d) of exchanging the crossing device with a guidewire and advancing the guidewire into a left atrium, a step (e) of removing the hybrid dilator, and a step (f) of advancing one or more secondary devices over the guidewire into the left atrium.
In some embodiments of using a hybrid dilator and a crossing device for puncturing a septum of a heart wherein the crossing device is configured for delivering energy, the crossing device is further configured for use as a guide-wire, and the method further comprises a step (d) of removing the hybrid dilator, and typically, a step (e) of advancing one or more secondary devices over the crossing device into a left atrium. Further details of crossing devices suitable for delivering energy and using as a guide-wire are given in international application PCT/IB2013/060287, entitled “METHODS AND DEVICES FOR PUNCTURING TISSUE”, which is hereby incorporated-by-reference in its entirety.
As such, in accordance with embodiments of the present invention, a method is provided for streamlining the procedural workflow by providing a hybrid dilator that combines the functionalities of a conventional transseptal sheath and dilator assembly. With the hybrid dilator of the present invention a reduced number of devices may be required in order to complete the transseptal procedure, which enhances procedural efficiency while reducing procedural time and complexity.
The problem of a transseptal puncture being performed using a crossing device which is supported by a sheath and dilator set having a transition which may snag on tissue when crossing the septum, can be addressed by using a hybrid dilator (described herein) instead of the sheath and dilator set to thereby eliminate the transition, wherein the hybrid dilator has the appropriate functionality (flexibility, pushability, torqueability, distal taper, etc.) to facilitate a smooth crossing.
The embodiment(s) of the invention described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the scope of the appended claims.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.
The present application is a continuation of U.S. patent application Ser. No. 16/068,589, filed on 12 Dec. 2018, which is a national phase application of International Application No. PCT/IB2017/050065, filed on 6 Jan. 2017, which claims priority from U.S. Provisional Application Ser. No. 62/275,907, filed on 7 Jan. 2016, each of which are incorporated in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
175254 | Oberly | Mar 1876 | A |
827626 | Gillet | Jul 1906 | A |
848711 | Weaver | Apr 1907 | A |
1072954 | Junn | Sep 1913 | A |
1279654 | Charlesworth | Sep 1918 | A |
1918094 | Geekas | Jul 1933 | A |
1996986 | Weinberg | Apr 1935 | A |
2021989 | De Master | Nov 1935 | A |
2146636 | Lipchow | Feb 1939 | A |
3429574 | Williams | Feb 1969 | A |
3448739 | Stark et al. | Jun 1969 | A |
3575415 | Fulp et al. | Apr 1971 | A |
3595239 | Petersen | Jul 1971 | A |
4129129 | Amrine | Dec 1978 | A |
4244362 | Anderson | Jan 1981 | A |
4401124 | Guess et al. | Aug 1983 | A |
4639252 | Kelly et al. | Jan 1987 | A |
4641649 | Walinsky et al. | Feb 1987 | A |
4669467 | Willett et al. | Jun 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4790311 | Ruiz | Dec 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
4793350 | Mar et al. | Dec 1988 | A |
4807620 | Strul et al. | Feb 1989 | A |
4832048 | Cohen | May 1989 | A |
4840622 | Hardy | Jun 1989 | A |
4863441 | Lindsay et al. | Sep 1989 | A |
4884567 | Elliott et al. | Dec 1989 | A |
4892104 | Ito et al. | Jan 1990 | A |
4896671 | Cunningham et al. | Jan 1990 | A |
4928693 | Goodin et al. | May 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4977897 | Hurwitz | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5006119 | Acker et al. | Apr 1991 | A |
5019076 | Yamanashi et al. | May 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5081997 | Bosley et al. | Jan 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5112048 | Kienle | May 1992 | A |
5154724 | Andrews | Oct 1992 | A |
5201756 | Horzewski et al. | Apr 1993 | A |
5209741 | Spaeth | May 1993 | A |
5211183 | Wilson | May 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5230349 | Edwin | Jul 1993 | A |
5281216 | Klicek | Jan 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5314418 | Takano et al. | May 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5327905 | Avitall | Jul 1994 | A |
5364393 | Auth et al. | Nov 1994 | A |
5372596 | Klicek et al. | Dec 1994 | A |
5380304 | Parker | Jan 1995 | A |
5397304 | Truckai | Mar 1995 | A |
5403338 | Milo | Apr 1995 | A |
5423809 | Klicek | Jun 1995 | A |
5425382 | Golden et al. | Jun 1995 | A |
5490859 | Mische et al. | Feb 1996 | A |
5497774 | Swartz et al. | Mar 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5509411 | Littmann et al. | Apr 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5545200 | West et al. | Aug 1996 | A |
5555618 | Winkler | Sep 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5575766 | Swartz et al. | Nov 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5599347 | Hart et al. | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5622169 | Golden et al. | Apr 1997 | A |
5624430 | Eton et al. | Apr 1997 | A |
5667488 | Lundquist et al. | Sep 1997 | A |
5673695 | McGee et al. | Oct 1997 | A |
5674208 | Berg et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5741249 | Moss et al. | Apr 1998 | A |
5766135 | Terwilliger | Jun 1998 | A |
5779688 | Imran et al. | Jul 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5814028 | Swartz et al. | Sep 1998 | A |
5830214 | Flom et al. | Nov 1998 | A |
5836875 | Webster, Jr. | Nov 1998 | A |
5849011 | Jones et al. | Dec 1998 | A |
5851210 | Torossian | Dec 1998 | A |
5885227 | Finlayson | Mar 1999 | A |
5888201 | Stinson et al. | Mar 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5893885 | Webster, Jr. | Apr 1999 | A |
5904679 | Clayman | May 1999 | A |
5916210 | Winston | Jun 1999 | A |
5921957 | Killion et al. | Jul 1999 | A |
5931818 | Werp et al. | Aug 1999 | A |
5944023 | Johnson et al. | Aug 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5957842 | Littmann et al. | Sep 1999 | A |
5964757 | Ponzi | Oct 1999 | A |
5967976 | Larsen et al. | Oct 1999 | A |
5989276 | Houser et al. | Nov 1999 | A |
6007555 | Devine | Dec 1999 | A |
6009877 | Edwards | Jan 2000 | A |
6013072 | Winston et al. | Jan 2000 | A |
6017340 | Cassidy et al. | Jan 2000 | A |
6018676 | Davis et al. | Jan 2000 | A |
6030380 | Auth et al. | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6048349 | Winston et al. | Apr 2000 | A |
6053870 | Fulton, III | Apr 2000 | A |
6053904 | Scribner et al. | Apr 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6063093 | Winston et al. | May 2000 | A |
6093185 | Ellis et al. | Jul 2000 | A |
6106515 | Winston et al. | Aug 2000 | A |
6106520 | Laufer et al. | Aug 2000 | A |
6117131 | Taylor | Sep 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6146380 | Racz et al. | Nov 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6156031 | Aita et al. | Dec 2000 | A |
6171305 | Sherman | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6193715 | Wrublewski et al. | Feb 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217575 | Devore et al. | Apr 2001 | B1 |
6221061 | Engelson et al. | Apr 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6245054 | Fuimaono et al. | Jun 2001 | B1 |
6267758 | Daw et al. | Jul 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6292678 | Hall et al. | Sep 2001 | B1 |
6293945 | Parins et al. | Sep 2001 | B1 |
6296615 | Brockway et al. | Oct 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6302898 | Edwards et al. | Oct 2001 | B1 |
6304769 | Arenson et al. | Oct 2001 | B1 |
6315777 | Comben | Nov 2001 | B1 |
6328699 | Eigler et al. | Dec 2001 | B1 |
6360128 | Kordis et al. | Mar 2002 | B2 |
6364877 | Goble et al. | Apr 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6394976 | Winston et al. | May 2002 | B1 |
6395002 | Ellman et al. | May 2002 | B1 |
6419674 | Bowser et al. | Jul 2002 | B1 |
6428551 | Hall et al. | Aug 2002 | B1 |
6450989 | Pubrul et al. | Sep 2002 | B2 |
6475214 | Moaddeb | Nov 2002 | B1 |
6485485 | Winston et al. | Nov 2002 | B1 |
6508754 | Liprie et al. | Jan 2003 | B1 |
6524303 | Garibaldi | Feb 2003 | B1 |
6530923 | Dubrul et al. | Mar 2003 | B1 |
6554827 | Chandrasekaran et al. | Apr 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6562049 | Norlander et al. | May 2003 | B1 |
6565562 | Shah et al. | May 2003 | B1 |
6607529 | Jones et al. | Aug 2003 | B1 |
6632222 | Edwards et al. | Oct 2003 | B1 |
6639999 | Cookingham et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6651672 | Roth | Nov 2003 | B2 |
6662034 | Segner et al. | Dec 2003 | B2 |
6663621 | Winston et al. | Dec 2003 | B1 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6709444 | Makower | Mar 2004 | B1 |
6723052 | Mills | Apr 2004 | B2 |
6733511 | Hall et al. | May 2004 | B2 |
6740103 | Hall et al. | May 2004 | B2 |
6752800 | Winston et al. | Jun 2004 | B1 |
6755816 | Ritter et al. | Jun 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6814733 | Schwartz et al. | Nov 2004 | B2 |
6820614 | Bonutti | Nov 2004 | B2 |
6834201 | Gillies et al. | Dec 2004 | B2 |
6842639 | Winston et al. | Jan 2005 | B1 |
6852109 | Winston et al. | Feb 2005 | B2 |
6855143 | Davison et al. | Feb 2005 | B2 |
6860856 | Ward et al. | Mar 2005 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6911026 | Hall et al. | Jun 2005 | B1 |
6951554 | Johansen et al. | Oct 2005 | B2 |
6951555 | Suresh et al. | Oct 2005 | B1 |
6955675 | Jain | Oct 2005 | B2 |
6970732 | Winston et al. | Nov 2005 | B2 |
6980843 | Eng et al. | Dec 2005 | B2 |
7029470 | Francischelli et al. | Apr 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7083566 | Tornes et al. | Aug 2006 | B2 |
7112197 | Hartley et al. | Sep 2006 | B2 |
7335197 | Sage et al. | Feb 2008 | B2 |
7618430 | Scheib | Nov 2009 | B2 |
7651492 | Wham | Jan 2010 | B2 |
7666203 | Chanduszko et al. | Feb 2010 | B2 |
7678081 | Whiting et al. | Mar 2010 | B2 |
7682360 | Guerra | Mar 2010 | B2 |
7828796 | Wong et al. | Nov 2010 | B2 |
7900928 | Held et al. | Mar 2011 | B2 |
8114110 | Bednarek et al. | Feb 2012 | B2 |
8192425 | Mirza et al. | Jun 2012 | B2 |
8257323 | Joseph et al. | Sep 2012 | B2 |
8388549 | Paul et al. | Mar 2013 | B2 |
8500697 | Kurth et al. | Aug 2013 | B2 |
8911415 | Knapp | Dec 2014 | B2 |
11339579 | Stearns | May 2022 | B1 |
11426565 | Thomspon Smith | Aug 2022 | B2 |
20010012934 | Chandrasekaran et al. | Aug 2001 | A1 |
20010021867 | Kordis et al. | Sep 2001 | A1 |
20020019644 | Hastings et al. | Feb 2002 | A1 |
20020022781 | McLntire et al. | Feb 2002 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20020087153 | Roschak et al. | Jul 2002 | A1 |
20020087156 | Maguire et al. | Jul 2002 | A1 |
20020111618 | Stewart et al. | Aug 2002 | A1 |
20020123749 | Jain | Sep 2002 | A1 |
20020147485 | Mamo et al. | Oct 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020188302 | Berg et al. | Dec 2002 | A1 |
20020198521 | Maguire | Dec 2002 | A1 |
20030032929 | McGuckin | Feb 2003 | A1 |
20030040742 | Underwood et al. | Feb 2003 | A1 |
20030083560 | Osypka | May 2003 | A1 |
20030144658 | Schwartz et al. | Jul 2003 | A1 |
20030158480 | Tornes et al. | Aug 2003 | A1 |
20030163153 | Scheib | Aug 2003 | A1 |
20030225392 | McMichael et al. | Dec 2003 | A1 |
20040015162 | McGaffigan | Jan 2004 | A1 |
20040024396 | Eggers | Feb 2004 | A1 |
20040030328 | Eggers et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040073243 | Sepetka et al. | Apr 2004 | A1 |
20040077948 | Molante et al. | Apr 2004 | A1 |
20040097881 | Brustad et al. | May 2004 | A1 |
20040116851 | Johansen et al. | Jun 2004 | A1 |
20040127963 | Uchida et al. | Jul 2004 | A1 |
20040133113 | Krishnan | Jul 2004 | A1 |
20040133130 | Ferry et al. | Jul 2004 | A1 |
20040143256 | Bednarek | Jul 2004 | A1 |
20040147950 | Mueller et al. | Jul 2004 | A1 |
20040181213 | Gondo | Sep 2004 | A1 |
20040230188 | Cioanta et al. | Nov 2004 | A1 |
20050004585 | Hall et al. | Jan 2005 | A1 |
20050010208 | Winston et al. | Jan 2005 | A1 |
20050049628 | Schweikert et al. | Mar 2005 | A1 |
20050059966 | McClurken et al. | Mar 2005 | A1 |
20050065507 | Hartley et al. | Mar 2005 | A1 |
20050070949 | Bakos et al. | Mar 2005 | A1 |
20050085806 | Auge et al. | Apr 2005 | A1 |
20050096529 | Cooper et al. | May 2005 | A1 |
20050101984 | Chanduszko et al. | May 2005 | A1 |
20050119556 | Gillies et al. | Jun 2005 | A1 |
20050137527 | Kunin | Jun 2005 | A1 |
20050149012 | Penny et al. | Jul 2005 | A1 |
20050203504 | Wham et al. | Sep 2005 | A1 |
20050203507 | Truckai et al. | Sep 2005 | A1 |
20050228364 | Braga | Oct 2005 | A1 |
20050261607 | Johansen et al. | Nov 2005 | A1 |
20050288631 | Lewis et al. | Dec 2005 | A1 |
20060041253 | Newton et al. | Feb 2006 | A1 |
20060064062 | Gurusamy et al. | Mar 2006 | A1 |
20060074398 | Whiting et al. | Apr 2006 | A1 |
20060079769 | Whiting et al. | Apr 2006 | A1 |
20060079787 | Whiting et al. | Apr 2006 | A1 |
20060079884 | Manzo et al. | Apr 2006 | A1 |
20060085054 | Zikorus et al. | Apr 2006 | A1 |
20060089638 | Carmel et al. | Apr 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060135962 | Kick et al. | Jun 2006 | A1 |
20060142756 | Davies et al. | Jun 2006 | A1 |
20060189972 | Grossman | Aug 2006 | A1 |
20060241586 | Wilk | Oct 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20060264927 | Ryan | Nov 2006 | A1 |
20060276710 | Krishnan | Dec 2006 | A1 |
20070060879 | Weitzner et al. | Mar 2007 | A1 |
20070066975 | Wong et al. | Mar 2007 | A1 |
20070118099 | Trout, III | May 2007 | A1 |
20070123964 | Davies et al. | May 2007 | A1 |
20070167775 | Kochavi et al. | Jul 2007 | A1 |
20070185522 | Davies | Aug 2007 | A1 |
20070208256 | Marilla | Sep 2007 | A1 |
20070225681 | House | Sep 2007 | A1 |
20070270791 | Wang et al. | Nov 2007 | A1 |
20080039865 | Shaher et al. | Feb 2008 | A1 |
20080042360 | Veikley | Feb 2008 | A1 |
20080086120 | Mirza et al. | Apr 2008 | A1 |
20080097213 | Carlson et al. | Apr 2008 | A1 |
20080108987 | Bruszewski et al. | May 2008 | A1 |
20080146918 | Magnin et al. | Jun 2008 | A1 |
20080171934 | Greenan et al. | Jul 2008 | A1 |
20080208121 | Youssef et al. | Aug 2008 | A1 |
20080275439 | Francischelli et al. | Nov 2008 | A1 |
20090105742 | Kurth et al. | Apr 2009 | A1 |
20090125097 | Bruszewski et al. | May 2009 | A1 |
20090138009 | Viswanathan et al. | May 2009 | A1 |
20090163850 | Betts et al. | Jun 2009 | A1 |
20090171276 | Bednarek | Jul 2009 | A1 |
20090177114 | Chin et al. | Jul 2009 | A1 |
20090264977 | Bruszewski et al. | Oct 2009 | A1 |
20100087789 | Leeflang et al. | Apr 2010 | A1 |
20100094258 | Shimogami | Apr 2010 | A1 |
20100125282 | Machek et al. | May 2010 | A1 |
20100168684 | Ryan | Jul 2010 | A1 |
20100179632 | Bruszewski et al. | Jul 2010 | A1 |
20100191142 | Paul et al. | Jul 2010 | A1 |
20100194047 | Sauerwine | Aug 2010 | A1 |
20100249491 | Farnan | Sep 2010 | A1 |
20110046619 | Ducharme | Feb 2011 | A1 |
20110152716 | Chudzik et al. | Jun 2011 | A1 |
20110160592 | Mitchell | Jun 2011 | A1 |
20110190763 | Urban et al. | Aug 2011 | A1 |
20120232546 | Mirza et al. | Sep 2012 | A1 |
20120265055 | Melsheimer et al. | Oct 2012 | A1 |
20120330156 | Brown et al. | Dec 2012 | A1 |
20130150793 | Beissel | Jun 2013 | A1 |
20130178841 | Reid, Jr. | Jul 2013 | A1 |
20130184551 | Paganelli et al. | Jul 2013 | A1 |
20130184735 | Fischell et al. | Jul 2013 | A1 |
20130282084 | Mathur et al. | Oct 2013 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140094645 | Lafontaine et al. | Apr 2014 | A1 |
20140200396 | Lashinski et al. | Jul 2014 | A1 |
20140206987 | Urbanski et al. | Jul 2014 | A1 |
20140276432 | Bierman | Sep 2014 | A1 |
20140296769 | Hyde et al. | Oct 2014 | A1 |
20150173782 | Garrison et al. | Jun 2015 | A1 |
20150173794 | Kurth et al. | Jun 2015 | A1 |
20150351793 | Bierman et al. | Dec 2015 | A1 |
20160220741 | Garrison et al. | Aug 2016 | A1 |
20190021763 | Zhou et al. | Jan 2019 | A1 |
20190247035 | Gittard et al. | Aug 2019 | A1 |
Number | Date | Country |
---|---|---|
2006-334242 | Dec 2006 | JP |
2015-533091 | Nov 2015 | JP |
2015048795 | Apr 2015 | WO |
2015136338 | Sep 2015 | WO |
2015192109 | Dec 2015 | WO |
Entry |
---|
International Search Report and Written Opinion received for PCT Patent Application No. PCT/IB2017/050065, mailed on Apr. 18, 2017, 16 pages. |
Patent Corporation Treaty, International Preliminary Report on Patentability, dated Jul. 10, 2018. |
Number | Date | Country | |
---|---|---|---|
20220355087 A1 | Nov 2022 | US |
Number | Date | Country | |
---|---|---|---|
62275907 | Jan 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16068589 | US | |
Child | 17813945 | US |